trending Market Intelligence /marketintelligence/en/news-insights/trending/wtNZ8OjmHyYtc1aEYHaPCQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Cresco Labs' C$1.1B acquisition of Origin House gets antitrust clearance

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Cresco Labs' C$1.1B acquisition of Origin House gets antitrust clearance

Cresco Labs Inc. said its C$1.1 billion acquisition of cannabis grower Origin House received antitrust clearance.

The waiting period under the Hart-Scott-Rodino Act in connection with the deal — the largest acquisition of a public company in the U.S. cannabis sector — has expired.

In September, Cresco and Origin House provided additional information to the U.S. Justice Department following a request by the federal agency. The request caused a delay in completion of the transaction.

Under the deal, Chicago-based Cresco, which manufactures medical cannabis products in the U.S., agreed to buy all existing and outstanding shares of Origin House at a rate of 0.8428 of a subordinate voting share of Cresco Labs per share held.

The deal is already approved by the shareholders of Ottawa, Ontario-based Origin House and the Ontario Superior Court of Justice. The boards of both companies have already approved the acquisition.

Cresco previously said the transaction is expected to close by Nov. 15.